OK
The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

Pebax® Rnew® 40R53 SP 01

Technical Datasheet | Supplied by Arkema
Pebax® Rnew® 40R53 SP 01 by Arkema is a bio-based polyether block amide grade, made of flexible polyether and rigid polyamide based on renewable resources. This grade has been developed to be heat- and UV resistant. It is composed of block copolymers consisting of a sequence of polyamide 11 and polyether segments. It is light stabilized. Designed for thermoforming, casting, transfer- and injection molding, film- and profile extrusion processing methods. Pebax® Rnew® 40R53 SP 01 is used in flexible injected parts. It has a shelf life of 2 years.
Product Type
PEBA (Polyether Block Amide) > PEBA (or COPA), Bio-based
Physical Form
Pellets
Product Status
COMMERCIAL
Applications/ Recommended for
  • Extrusion > Profiles
  • Injection molding - thermoplastics
  • Thermoforming/ Vaccuum forming
Bio Based
Yes
Bio Based Content (%)
44-48
Key Features
  • Flexibility, Good
  • Heat Resistance, High
  • Light Stabilized
  • Renewable Resource Content
  • UV Resistance, Good

Pebax® Rnew® 40R53 SP 01 Properties

Mechanical Properties

Value & Unit
Test Condition
Test Method
Tensile Strength
8.2 MPa
(At 50% Strain, Conditioned)
ISO 527-1/-2
Tensile Strain
> 50 %
(At Break, Conditioned)
ISO 527-1/-2
Impact Strength, Charpy
No Break kJ/m2
(At -30°C)
ISO 179/1eU

Pebax® Rnew® 40R53 SP 01 Processing Guidelines

Injection Molding Properties

Value & Unit
Test Condition
Test Method
Melt Temperature
220 °C
Mold Temperature
10 - 30 °C

Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 93366 Plastics & Elastomers,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top